4D MOLECULAR THERAPEUTICS IN (FDMT) Stock Analyst Ratings
NASDAQ:FDMT - Nasdaq - US35104E1001 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to FDMT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 30.37. This target is 817.62% above the current price.
FDMT was analyzed by 17 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about FDMT.
In the previous month the buy percentage consensus was at a similar level.
FDMT was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-04 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-13 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-01-13 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-18 | B of A Securities | Maintains | Buy -> Buy |
| 2024-11-21 | Morgan Stanley | Initiate | Underweight |
| 2024-11-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-23 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2024-09-19 | Leerink Partners | Reiterate | Outperform -> Outperform |
| 2024-09-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-22 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-18 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-07-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-06-26 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-15 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-04-15 | Barclays | Initiate | Overweight |
| 2024-04-01 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-04-01 | Jefferies | Maintains | Buy -> Buy |